533
Views
58
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Relationship between fecal lactoferrin and inflammatory bowel disease

, , , &
Pages 1440-1444 | Received 06 Feb 2007, Published online: 08 Jul 2009

References

  • Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. Br Med J 1989; 298: 82–6
  • Truelove SC, Witts LJ. Cortisone in ulcerative colitis: final report on a therapeutic trial. Br Med J 1955; 4947: 1041–8
  • Powell-Tuck J, Bown RL, Lennard-Jones JE. A comparison of oral prednisolone given as single or multiple daily doses for active proctocolitis. Scand J Gastroenterol 1978; 13: 833–7
  • Sutherland LR, Martin F, Greer S, Robinson M, Greenberger N, Saibil F, et al. 5-aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology 1987; 92: 1894–8
  • Crama-Bohbouth G, Pena AS, Biemond I, Verspaget HW, Blok D, Arndt JW, et al. Are activity indices helpful in assessing active intestinal inflammation in Crohn's diseases. Gut 1989; 30: 1236–40
  • Levay PF, Viljoen M. Lactoferrin: A general review. Haematologica 1995; 80: 256–67
  • Baveye S, Elass E, Mazurier J, Spik G, Legrand D. Lactoferrin: a multifunction glycoprotein involved in the modulation of the inflammatory response. Clin Chem Lab Med 1999; 37: 281–6
  • Guerrant RL, Araujo V, Soares E, Kotloff K, Lima A, Cooper W, et al. Measurement of fecal lactoferrin as a marker of fecal leukocytes. J Clin Microbiol 1992; 30: 1238–42
  • Kane SV, Sandborn WJ, Rufo PA, Zholudev A, Boone J, Lyerly D, et al. Fecal Lactoferrin is a sensitive and special marker in identifying intestinal inflammation. Am J Gastroenterol 2003; 6: 1309–14
  • Hammer J, Talley NJ. Diagnostic criteria for the irritable bowel syndrome. Am J Med 1999; 107: 5–11
  • Langhorst J, Elsenbruch S, Mueller T, Rueffer A, Spahn G, Michalsen A, et al. Comparison of 4 neutrophil-derived proteins in feces as indicators of disease activity in ulcerative colitis. Inflamm Bowel Dis 2005; 11: 1085–91
  • Kayazawa M, Saitoh O, Kojima K, Nakagawa K, Tanaka S, Tabata K, et al. Lactoferrin in whole gut lavage fluid as a marker for disease activity in inflammatory bowel disease: comparison with other neutrophil-derived proteins. Am J Gastroenterol 2002; 97: 360–9
  • Sugi K, Saitoh O, Hirata I, Katsu K. Fecal lactoferrin as a marker for disease activity in inflammatory bowel disease: comparison with other neutrophil-derived proteins. Am J Gastroenterol 1996; 91: 927–34
  • Roseth AG, Fagerhol MK, Aadland E, Schjonsby H. Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study. Scand J Gastroenterol 1992; 27: 793–8
  • Guerrant RL, Araujo V, Soares E, Kotloff K, Lima AA, Cooper WH, et al. Measurement of fecal lactoferrin as a marker of fecal leukocytes. J Clin Microbiol 1992; 30: 1238–42
  • Steiner TS, Flores CA, Pizarro TT, Guerrant RL. Fecal lactoferrin, interleukin-1 beta, and interleukin-8 are elevated in patients with severe Clostridium difficile colitis. Clin Diagn Lab Immunol 1997; 4: 719–22
  • Fine KD, Ogunji F, George J, Niehaus M, Guerrant R. Utility of a rapid fecal latex agglutination test detecting the neutrophil protein, lactoferrin, for diagnosing inflammatory causes of chronic diarrhea. Am J. Gastroenterol 1998; 93: 1300–5
  • Suleiman S, Sonnenberg A. Cost-effectiveness of endoscopy in irritable bowel syndrome. Arch Intern Med 2001; 161: 369–75
  • Huicho L, Garaycochea V, Uchima N, Zerpa R, Guerrant RL. Fecal lactoferrin, fecal leukocytes and occult blood in the diagnostic approach to childhood invasive diarrhea. J Pediatr Infect Dis 1997; 16: 644–7

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.